 | • レポートコード：QYR2104Z3181 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、不眠症薬理学的治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（処方睡眠薬、市販睡眠薬）、用途別市場規模（在宅ケア、クリニック、病院）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・不眠症薬理学的治療の市場動向 ・企業の競争状況、市場シェア ・不眠症薬理学的治療の種類別市場規模（処方睡眠薬、市販睡眠薬） ・不眠症薬理学的治療の用途別市場規模（在宅ケア、クリニック、病院） ・不眠症薬理学的治療の北米市場規模2016-2027（アメリカ、カナダ） ・不眠症薬理学的治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・不眠症薬理学的治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・不眠症薬理学的治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・不眠症薬理学的治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Eisai, Co. Ltd. (Japan)、Merck & Co., Inc (US)、Meda Consumer Healthcare Inc (US)、Pfizer, Inc (US)、Sanofi (France)、Takeda Pharmaceutical Company Ltd. (Japan)、Pernix Therapeutics (US)、Purdue Pharma L.P (US)） ・結論 |
Market Analysis and Insights: Global Insomnia Pharmacological Treatment Market
The global Insomnia Pharmacological Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Insomnia Pharmacological Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Insomnia Pharmacological Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Insomnia Pharmacological Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Insomnia Pharmacological Treatment market.
Global Insomnia Pharmacological Treatment Scope and Market Size
Insomnia Pharmacological Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Insomnia Pharmacological Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Prescription Sleep Aids
Over-the-Counter Sleep Aids
Segment by Application
Homecare
Clinic
Hospital
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Eisai, Co. Ltd. (Japan)
Merck & Co., Inc (US)
Meda Consumer Healthcare Inc (US)
Pfizer, Inc (US)
Sanofi (France)
Takeda Pharmaceutical Company Ltd. (Japan)
Pernix Therapeutics (US)
Purdue Pharma L.P (US)
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Insomnia Pharmacological Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Prescription Sleep Aids
1.2.3 Over-the-Counter Sleep Aids
1.3 Market by Application
1.3.1 Global Insomnia Pharmacological Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Homecare
1.3.3 Clinic
1.3.4 Hospital
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Insomnia Pharmacological Treatment Market Perspective (2016-2027)
2.2 Insomnia Pharmacological Treatment Growth Trends by Regions
2.2.1 Insomnia Pharmacological Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Insomnia Pharmacological Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Insomnia Pharmacological Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Insomnia Pharmacological Treatment Industry Dynamic
2.3.1 Insomnia Pharmacological Treatment Market Trends
2.3.2 Insomnia Pharmacological Treatment Market Drivers
2.3.3 Insomnia Pharmacological Treatment Market Challenges
2.3.4 Insomnia Pharmacological Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Insomnia Pharmacological Treatment Players by Revenue
3.1.1 Global Top Insomnia Pharmacological Treatment Players by Revenue (2016-2021)
3.1.2 Global Insomnia Pharmacological Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Insomnia Pharmacological Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Insomnia Pharmacological Treatment Revenue
3.4 Global Insomnia Pharmacological Treatment Market Concentration Ratio
3.4.1 Global Insomnia Pharmacological Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Insomnia Pharmacological Treatment Revenue in 2020
3.5 Insomnia Pharmacological Treatment Key Players Head office and Area Served
3.6 Key Players Insomnia Pharmacological Treatment Product Solution and Service
3.7 Date of Enter into Insomnia Pharmacological Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Insomnia Pharmacological Treatment Breakdown Data by Type
4.1 Global Insomnia Pharmacological Treatment Historic Market Size by Type (2016-2021)
4.2 Global Insomnia Pharmacological Treatment Forecasted Market Size by Type (2022-2027)
5 Insomnia Pharmacological Treatment Breakdown Data by Application
5.1 Global Insomnia Pharmacological Treatment Historic Market Size by Application (2016-2021)
5.2 Global Insomnia Pharmacological Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Insomnia Pharmacological Treatment Market Size (2016-2027)
6.2 North America Insomnia Pharmacological Treatment Market Size by Type
6.2.1 North America Insomnia Pharmacological Treatment Market Size by Type (2016-2021)
6.2.2 North America Insomnia Pharmacological Treatment Market Size by Type (2022-2027)
6.2.3 North America Insomnia Pharmacological Treatment Market Size by Type (2016-2027)
6.3 North America Insomnia Pharmacological Treatment Market Size by Application
6.3.1 North America Insomnia Pharmacological Treatment Market Size by Application (2016-2021)
6.3.2 North America Insomnia Pharmacological Treatment Market Size by Application (2022-2027)
6.3.3 North America Insomnia Pharmacological Treatment Market Size by Application (2016-2027)
6.4 North America Insomnia Pharmacological Treatment Market Size by Country
6.4.1 North America Insomnia Pharmacological Treatment Market Size by Country (2016-2021)
6.4.2 North America Insomnia Pharmacological Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Insomnia Pharmacological Treatment Market Size (2016-2027)
7.2 Europe Insomnia Pharmacological Treatment Market Size by Type
7.2.1 Europe Insomnia Pharmacological Treatment Market Size by Type (2016-2021)
7.2.2 Europe Insomnia Pharmacological Treatment Market Size by Type (2022-2027)
7.2.3 Europe Insomnia Pharmacological Treatment Market Size by Type (2016-2027)
7.3 Europe Insomnia Pharmacological Treatment Market Size by Application
7.3.1 Europe Insomnia Pharmacological Treatment Market Size by Application (2016-2021)
7.3.2 Europe Insomnia Pharmacological Treatment Market Size by Application (2022-2027)
7.3.3 Europe Insomnia Pharmacological Treatment Market Size by Application (2016-2027)
7.4 Europe Insomnia Pharmacological Treatment Market Size by Country
7.4.1 Europe Insomnia Pharmacological Treatment Market Size by Country (2016-2021)
7.4.2 Europe Insomnia Pharmacological Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Insomnia Pharmacological Treatment Market Size (2016-2027)
8.2 Asia-Pacific Insomnia Pharmacological Treatment Market Size by Type
8.2.1 Asia-Pacific Insomnia Pharmacological Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Insomnia Pharmacological Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Insomnia Pharmacological Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Insomnia Pharmacological Treatment Market Size by Application
8.3.1 Asia-Pacific Insomnia Pharmacological Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Insomnia Pharmacological Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Insomnia Pharmacological Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Insomnia Pharmacological Treatment Market Size by Region
8.4.1 Asia-Pacific Insomnia Pharmacological Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Insomnia Pharmacological Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Insomnia Pharmacological Treatment Market Size (2016-2027)
9.2 Latin America Insomnia Pharmacological Treatment Market Size by Type
9.2.1 Latin America Insomnia Pharmacological Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Insomnia Pharmacological Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Insomnia Pharmacological Treatment Market Size by Type (2016-2027)
9.3 Latin America Insomnia Pharmacological Treatment Market Size by Application
9.3.1 Latin America Insomnia Pharmacological Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Insomnia Pharmacological Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Insomnia Pharmacological Treatment Market Size by Application (2016-2027)
9.4 Latin America Insomnia Pharmacological Treatment Market Size by Country
9.4.1 Latin America Insomnia Pharmacological Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Insomnia Pharmacological Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Insomnia Pharmacological Treatment Market Size (2016-2027)
10.2 Middle East & Africa Insomnia Pharmacological Treatment Market Size by Type
10.2.1 Middle East & Africa Insomnia Pharmacological Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Insomnia Pharmacological Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Insomnia Pharmacological Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Insomnia Pharmacological Treatment Market Size by Application
10.3.1 Middle East & Africa Insomnia Pharmacological Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Insomnia Pharmacological Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Insomnia Pharmacological Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Insomnia Pharmacological Treatment Market Size by Country
10.4.1 Middle East & Africa Insomnia Pharmacological Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Insomnia Pharmacological Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Eisai, Co. Ltd. (Japan)
11.1.1 Eisai, Co. Ltd. (Japan) Company Details
11.1.2 Eisai, Co. Ltd. (Japan) Business Overview
11.1.3 Eisai, Co. Ltd. (Japan) Insomnia Pharmacological Treatment Introduction
11.1.4 Eisai, Co. Ltd. (Japan) Revenue in Insomnia Pharmacological Treatment Business (2016-2021)
11.1.5 Eisai, Co. Ltd. (Japan) Recent Development
11.2 Merck & Co., Inc (US)
11.2.1 Merck & Co., Inc (US) Company Details
11.2.2 Merck & Co., Inc (US) Business Overview
11.2.3 Merck & Co., Inc (US) Insomnia Pharmacological Treatment Introduction
11.2.4 Merck & Co., Inc (US) Revenue in Insomnia Pharmacological Treatment Business (2016-2021)
11.2.5 Merck & Co., Inc (US) Recent Development
11.3 Meda Consumer Healthcare Inc (US)
11.3.1 Meda Consumer Healthcare Inc (US) Company Details
11.3.2 Meda Consumer Healthcare Inc (US) Business Overview
11.3.3 Meda Consumer Healthcare Inc (US) Insomnia Pharmacological Treatment Introduction
11.3.4 Meda Consumer Healthcare Inc (US) Revenue in Insomnia Pharmacological Treatment Business (2016-2021)
11.3.5 Meda Consumer Healthcare Inc (US) Recent Development
11.4 Pfizer, Inc (US)
11.4.1 Pfizer, Inc (US) Company Details
11.4.2 Pfizer, Inc (US) Business Overview
11.4.3 Pfizer, Inc (US) Insomnia Pharmacological Treatment Introduction
11.4.4 Pfizer, Inc (US) Revenue in Insomnia Pharmacological Treatment Business (2016-2021)
11.4.5 Pfizer, Inc (US) Recent Development
11.5 Sanofi (France)
11.5.1 Sanofi (France) Company Details
11.5.2 Sanofi (France) Business Overview
11.5.3 Sanofi (France) Insomnia Pharmacological Treatment Introduction
11.5.4 Sanofi (France) Revenue in Insomnia Pharmacological Treatment Business (2016-2021)
11.5.5 Sanofi (France) Recent Development
11.6 Takeda Pharmaceutical Company Ltd. (Japan)
11.6.1 Takeda Pharmaceutical Company Ltd. (Japan) Company Details
11.6.2 Takeda Pharmaceutical Company Ltd. (Japan) Business Overview
11.6.3 Takeda Pharmaceutical Company Ltd. (Japan) Insomnia Pharmacological Treatment Introduction
11.6.4 Takeda Pharmaceutical Company Ltd. (Japan) Revenue in Insomnia Pharmacological Treatment Business (2016-2021)
11.6.5 Takeda Pharmaceutical Company Ltd. (Japan) Recent Development
11.7 Pernix Therapeutics (US)
11.7.1 Pernix Therapeutics (US) Company Details
11.7.2 Pernix Therapeutics (US) Business Overview
11.7.3 Pernix Therapeutics (US) Insomnia Pharmacological Treatment Introduction
11.7.4 Pernix Therapeutics (US) Revenue in Insomnia Pharmacological Treatment Business (2016-2021)
11.7.5 Pernix Therapeutics (US) Recent Development
11.8 Purdue Pharma L.P (US)
11.8.1 Purdue Pharma L.P (US) Company Details
11.8.2 Purdue Pharma L.P (US) Business Overview
11.8.3 Purdue Pharma L.P (US) Insomnia Pharmacological Treatment Introduction
11.8.4 Purdue Pharma L.P (US) Revenue in Insomnia Pharmacological Treatment Business (2016-2021)
11.8.5 Purdue Pharma L.P (US) Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Insomnia Pharmacological Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Prescription Sleep Aids
Table 3. Key Players of Over-the-Counter Sleep Aids
Table 4. Global Insomnia Pharmacological Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Insomnia Pharmacological Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Insomnia Pharmacological Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Insomnia Pharmacological Treatment Market Share by Regions (2016-2021)
Table 8. Global Insomnia Pharmacological Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Insomnia Pharmacological Treatment Market Share by Regions (2022-2027)
Table 10. Insomnia Pharmacological Treatment Market Trends
Table 11. Insomnia Pharmacological Treatment Market Drivers
Table 12. Insomnia Pharmacological Treatment Market Challenges
Table 13. Insomnia Pharmacological Treatment Market Restraints
Table 14. Global Insomnia Pharmacological Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Insomnia Pharmacological Treatment Market Share by Players (2016-2021)
Table 16. Global Top Insomnia Pharmacological Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insomnia Pharmacological Treatment as of 2020)
Table 17. Ranking of Global Top Insomnia Pharmacological Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Insomnia Pharmacological Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Insomnia Pharmacological Treatment Product Solution and Service
Table 21. Date of Enter into Insomnia Pharmacological Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Insomnia Pharmacological Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Insomnia Pharmacological Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Insomnia Pharmacological Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Insomnia Pharmacological Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Insomnia Pharmacological Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Insomnia Pharmacological Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Insomnia Pharmacological Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Insomnia Pharmacological Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Insomnia Pharmacological Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Insomnia Pharmacological Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Insomnia Pharmacological Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Insomnia Pharmacological Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Insomnia Pharmacological Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Insomnia Pharmacological Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Insomnia Pharmacological Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Insomnia Pharmacological Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Insomnia Pharmacological Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Insomnia Pharmacological Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Insomnia Pharmacological Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Insomnia Pharmacological Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Insomnia Pharmacological Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Insomnia Pharmacological Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Insomnia Pharmacological Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Insomnia Pharmacological Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Insomnia Pharmacological Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Insomnia Pharmacological Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Insomnia Pharmacological Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Insomnia Pharmacological Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Insomnia Pharmacological Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Insomnia Pharmacological Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Insomnia Pharmacological Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Insomnia Pharmacological Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Insomnia Pharmacological Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Insomnia Pharmacological Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Insomnia Pharmacological Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Insomnia Pharmacological Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Insomnia Pharmacological Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Insomnia Pharmacological Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Eisai, Co. Ltd. (Japan) Company Details
Table 62. Eisai, Co. Ltd. (Japan) Business Overview
Table 63. Eisai, Co. Ltd. (Japan) Insomnia Pharmacological Treatment Product
Table 64. Eisai, Co. Ltd. (Japan) Revenue in Insomnia Pharmacological Treatment Business (2016-2021) & (US$ Million)
Table 65. Eisai, Co. Ltd. (Japan) Recent Development
Table 66. Merck & Co., Inc (US) Company Details
Table 67. Merck & Co., Inc (US) Business Overview
Table 68. Merck & Co., Inc (US) Insomnia Pharmacological Treatment Product
Table 69. Merck & Co., Inc (US) Revenue in Insomnia Pharmacological Treatment Business (2016-2021) & (US$ Million)
Table 70. Merck & Co., Inc (US) Recent Development
Table 71. Meda Consumer Healthcare Inc (US) Company Details
Table 72. Meda Consumer Healthcare Inc (US) Business Overview
Table 73. Meda Consumer Healthcare Inc (US) Insomnia Pharmacological Treatment Product
Table 74. Meda Consumer Healthcare Inc (US) Revenue in Insomnia Pharmacological Treatment Business (2016-2021) & (US$ Million)
Table 75. Meda Consumer Healthcare Inc (US) Recent Development
Table 76. Pfizer, Inc (US) Company Details
Table 77. Pfizer, Inc (US) Business Overview
Table 78. Pfizer, Inc (US) Insomnia Pharmacological Treatment Product
Table 79. Pfizer, Inc (US) Revenue in Insomnia Pharmacological Treatment Business (2016-2021) & (US$ Million)
Table 80. Pfizer, Inc (US) Recent Development
Table 81. Sanofi (France) Company Details
Table 82. Sanofi (France) Business Overview
Table 83. Sanofi (France) Insomnia Pharmacological Treatment Product
Table 84. Sanofi (France) Revenue in Insomnia Pharmacological Treatment Business (2016-2021) & (US$ Million)
Table 85. Sanofi (France) Recent Development
Table 86. Takeda Pharmaceutical Company Ltd. (Japan) Company Details
Table 87. Takeda Pharmaceutical Company Ltd. (Japan) Business Overview
Table 88. Takeda Pharmaceutical Company Ltd. (Japan) Insomnia Pharmacological Treatment Product
Table 89. Takeda Pharmaceutical Company Ltd. (Japan) Revenue in Insomnia Pharmacological Treatment Business (2016-2021) & (US$ Million)
Table 90. Takeda Pharmaceutical Company Ltd. (Japan) Recent Development
Table 91. Pernix Therapeutics (US) Company Details
Table 92. Pernix Therapeutics (US) Business Overview
Table 93. Pernix Therapeutics (US) Insomnia Pharmacological Treatment Product
Table 94. Pernix Therapeutics (US) Revenue in Insomnia Pharmacological Treatment Business (2016-2021) & (US$ Million)
Table 95. Pernix Therapeutics (US) Recent Development
Table 96. Purdue Pharma L.P (US) Company Details
Table 97. Purdue Pharma L.P (US) Business Overview
Table 98. Purdue Pharma L.P (US) Revenue in Insomnia Pharmacological Treatment Business (2016-2021) & (US$ Million)
Table 99. Purdue Pharma L.P (US) Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Insomnia Pharmacological Treatment Market Share by Type: 2020 VS 2027
Figure 2. Prescription Sleep Aids Features
Figure 3. Over-the-Counter Sleep Aids Features
Figure 4. Global Insomnia Pharmacological Treatment Market Share by Application: 2020 VS 2027
Figure 5. Homecare Case Studies
Figure 6. Clinic Case Studies
Figure 7. Hospital Case Studies
Figure 8. Insomnia Pharmacological Treatment Report Years Considered
Figure 9. Global Insomnia Pharmacological Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Insomnia Pharmacological Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Insomnia Pharmacological Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Insomnia Pharmacological Treatment Market Share by Regions (2022-2027)
Figure 13. Global Insomnia Pharmacological Treatment Market Share by Players in 2020
Figure 14. Global Top Insomnia Pharmacological Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insomnia Pharmacological Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Insomnia Pharmacological Treatment Revenue in 2020
Figure 16. Global Insomnia Pharmacological Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Insomnia Pharmacological Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Insomnia Pharmacological Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Insomnia Pharmacological Treatment Market Share by Type (2016-2027)
Figure 20. North America Insomnia Pharmacological Treatment Market Share by Application (2016-2027)
Figure 21. North America Insomnia Pharmacological Treatment Market Share by Country (2016-2027)
Figure 22. United States Insomnia Pharmacological Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Insomnia Pharmacological Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Insomnia Pharmacological Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Insomnia Pharmacological Treatment Market Share by Type (2016-2027)
Figure 26. Europe Insomnia Pharmacological Treatment Market Share by Application (2016-2027)
Figure 27. Europe Insomnia Pharmacological Treatment Market Share by Country (2016-2027)
Figure 28. Germany Insomnia Pharmacological Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Insomnia Pharmacological Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Insomnia Pharmacological Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Insomnia Pharmacological Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Insomnia Pharmacological Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Insomnia Pharmacological Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Insomnia Pharmacological Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Insomnia Pharmacological Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Insomnia Pharmacological Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Insomnia Pharmacological Treatment Market Share by Region (2016-2027)
Figure 38. China Insomnia Pharmacological Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Insomnia Pharmacological Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Insomnia Pharmacological Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Insomnia Pharmacological Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Insomnia Pharmacological Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Insomnia Pharmacological Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Insomnia Pharmacological Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Insomnia Pharmacological Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Insomnia Pharmacological Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Insomnia Pharmacological Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Insomnia Pharmacological Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Insomnia Pharmacological Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Insomnia Pharmacological Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Insomnia Pharmacological Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Insomnia Pharmacological Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Insomnia Pharmacological Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Insomnia Pharmacological Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Insomnia Pharmacological Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Insomnia Pharmacological Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Eisai, Co. Ltd. (Japan) Revenue Growth Rate in Insomnia Pharmacological Treatment Business (2016-2021)
Figure 58. Merck & Co., Inc (US) Revenue Growth Rate in Insomnia Pharmacological Treatment Business (2016-2021)
Figure 59. Meda Consumer Healthcare Inc (US) Revenue Growth Rate in Insomnia Pharmacological Treatment Business (2016-2021)
Figure 60. Pfizer, Inc (US) Revenue Growth Rate in Insomnia Pharmacological Treatment Business (2016-2021)
Figure 61. Sanofi (France) Revenue Growth Rate in Insomnia Pharmacological Treatment Business (2016-2021)
Figure 62. Takeda Pharmaceutical Company Ltd. (Japan) Revenue Growth Rate in Insomnia Pharmacological Treatment Business (2016-2021)
Figure 63. Pernix Therapeutics (US) Revenue Growth Rate in Insomnia Pharmacological Treatment Business (2016-2021)
Figure 64. Purdue Pharma L.P (US) Revenue Growth Rate in Insomnia Pharmacological Treatment Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
世界の不眠症市場規模・現状・予測（2021年-2027年） Insomnia is a sleep disorder where people have trouble sleeping. They may have difficulty falling asleep, or staying asleep as long as desired. Insomnia is typically followed by daytime sleepiness, low energy, irritability, and a depressed mood. Sleep hygiene and lifestyle changes are typically the …- 世界の不眠症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Insomnia Therapy Market The global Insomnia Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a b…
- 世界の不眠症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Insomnia Therapy Market The global Insomnia Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a b…
- 世界の不眠症治療薬市場 2021：企業別、地域別、種類・用途別 The Insomnia Therapeutics Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…
- 世界の睡眠障害治療薬市場規模・現状・予測（2021年-2027年） Sleep disorders result in a lack of deep and restorative sleep. The sleep disorder therapeutics market is expected to witness a high growth over the forecast period owing to the increasing prevalence of sleep disorder in modern times. Market Analysis and Insights: Global Sleep Disorder Therapeutics …